December 15-16, 2021
Online Livestream
5th VirtualClinical Trials
Days
Hours
Minutes
Seconds
With more clinical trials switching to fully decentralized and hybrid models, the need for a collaborative information exchange is more important than ever. At the 5th Virtual Clinical Trials Conference, hear actual case studies from current decentralized trials and discuss the future state of clinical research from top industry experts at the forefront of clinical trial designs. Explore what is working successfully and what obstacles you can avoid in data compliance, regulatory compliance and novel submission methods.
This is the industry’s leading, longest-lasting and most trusted conference on decentralized trials, offering you exclusive insights our speaking faculty hasn’t shared anywhere else! Join us in December for all-new insights on constructing and measuring endpoints, executing effective patient recruitment strategies, applying innovative technologies – and much more!
“The lessons presented actually reflected on examples of implementation and the lessons learned”
Innovation Manager – BAYER
“I wanted to understand more about where other pharma companies are in the process of building up these platforms, this exceeded my expectations”
Director, NOVO NORDISK
Top Reasons to Attend
  • Implement effective trial design techniques and SOPS to improve your internal processes
  • Enhance patient enrollment, safety monitoring and follow up outcomes
  • Ensure quantification measures and trial value issues are being addressed
  • New clinical trial regulatory considerations from the FDA, EMA and GDPR addressed
  • Maximize collaboration approaches to ensure quality in your decentralized approach
  • Hear from new and exciting technologies that will increase efficiencies in your trials
Who Should Attend
This conference is designed for pharmaceutical, biotech, and medical device professionals responsible for:
  • Clinical Data
  • Clinical Operations
  • Clinical Projects
  • Patient Solutions
  • Patient Experience
  • Patient Recruitment
  • Remote Monitoring
  • Trial Design
  • Decentralized Trials
  • Clinical Trials
  • Clinical Supply Chain
  • Clinical Trial Supply Management / CTSM
  • Clinical Technology
  • Clinical Research
  • Clinical Sciences / Clinical Scientific Affairs
  • Digital Health
  • Scientific Affairs
  • Clinical Systems
  • Clinical Processes
  • Medical Affairs
  • Medical Advisors
  • Clinical Safety
  • Clinical Regulatory Affairs
  • Operational Strategy
  • Outsourcing
  • R&D
  • Site Solutions
  • Data Management
  • Digital Strategy
  • Technical Solutions
  • Medical Director
  • Medical Affairs
  • Digital Engagement
  • Quality Planning
  • Information Technology
  • Site Management
  • Strategy and Innovation
  • Procurement
  • Regulatory Affairs
  • Business Development
  • Clinical Affairs
  • Clinical Development
  • CQA Auditor
  • Clinical Project Management
Event Sponsors
Conference
New Topics
Featured Speakers
Amy Apostoleris
Global Head, Digital Clinical Trials Solutions
MEDOCITY
Beth Metzheiser
Executive Director, Immunology, Fibrosis & Cardiovascular, Global Development Operations
BMS
Bjarke Staerkind
R&D Project Manager
LEO PHARMA
Gorgio Quer
Director, Artificial Intelligence
SCRIPPS RESEARCH
Jennifer Hedglin
RN Clinical Research Nurse, Phase I, Targeted and Immunotherapy Combination Trial
DANA FARBER CANCER INSTITUTE
Jeremy Price
Senior Director, Clinical Innovation & Strategic Partnerships
PFIZER
John Cassidy
Global Head of Product & Commercial, eClinical
LABCORP
John Reites
CEO
THREAD
Kendal Whitlock
Metasite Strategic Engagement Lead
BOEHRINGER INGELHEIM
Liz Nevin
IT Capability Lead, Digital Therapeutics, Precision Medicine & Bio Samples
ASTRAZENECA
Lydia Matombo
Associate Director - Clinical Data Management
MERCK
Sandeepm Bhat
Senior Leader, Digital Engagement, Global Clinical Operations
GLAXOSMITHKLINE
Sarah Krug
Executive Director
CANCER 101
Event Schedule
ALL TIMES ARE IN EST
Evaluate design strategies to best fit your organization needs, from innovation to business as usual. Hear direct from a 2021 remote trial, learn from the pitfalls and tribulations they encountered in the design.
  • Involve all stakeholders in the design process
  • Ensure to implement effective technologies and tools when planning
  • Decrease the clutter and complexity, simplification tactics to deploy
Are we providing enough resources for our patients? Understand the patient’s willingness to be flexible to participate in a combination of both telehealth and in person visits.
  • Improve your trial design considering patient experiences and nursing capabilities
  • Provide a balance between ensuring excellent patient care and also maintaining the integrity of the protocol
  • Hear why research nurses are referred to as the gatekeepers for the study
  • Gaps and risk factors in providing remote services and home visits as part of decentralized clinical trials
  • Discuss how new tools and integrative technologies can be applied to improve the patient experience and improve site efficiency
  • Discover the benefits of using a comprehensive digital platform integrated with Mobile Clinical Services
  • Explore real world scenarios showing how these solutions can be applied to various therapeutic areas for unique use cases
Being risk adverse, change is a big issue in the life sciences world and goes against a system that is already working. Now, every corner of the health care ecosystem is in a mode of adaptation and there is simply no substitute for an agile team that can quickly troubleshoot and implement new systems and processes to resolve issues.
  • Adapt protocols and operations to continue in the face of the COVID19 pandemic to the benefit of patients
  • Build foundational trust between the sites, patients and sponsors
  • Digitally enable workflows and engagement platforms that will simplify clinical trials processes leading to fewer errors and shorter timelines
Doing the right thing by making trials more accessible is now in the financial interest of everyone conducting clinical research. Carry out decentralized approaches offers opportunities to reduce and, in some cases, remove high-cost areas.
  • Discuss ways to reduce administration costs, site monitoring costs and clinical procedure costs
  • Work through initial cost analysis and value
  • Adapt to lower cost strategies through improved patient engagement and retention
Now that we are running more DCTs than ever, this is an opportunity to detect how to use wearable devices and artificial intelligence to enable clinical trial sponsors to recognize and contextualize patient reported outcomes in a manner previously not possible.
  • Select the right devices or sensors to measure specific outcomes at the right frequency
  • Align the vendor’s interface for easy data transfer
  • Consider device selection carefully to prevent launch delays and operational challenges
The new business opportunity is uniquely positioned to continue delivering research solutions for COVID-19 and beyond with community presence, data capabilities and health care expertise. The national and local reach capabilities will engage with new populations and teach about the clinical trial opportunities that may be right for them.
  • Use pharmacies as new sites or a secondary site system , partnering with primary sites and CRO’s
  • Increase the capacity to deliver late-stage clinical testing, and real-world evaluation of products in the store, in people’s homes, or virtually
  • Hear project management strategies to use pharmacies effectively in your next DCT
ALL TIMES ARE IN EST
The way clinical trials are conducted in the European Union (EU) will undergo a major change when the Clinical Trials Regulation (Regulation (EU) No 536/2014) comes into application on January 31, 2022 repealing the existing directive.
  • Exhibit how to successfully present findings to regulatory authorities and get approvals with ease
  • Understand regulatory considerations and more integration in the trial
  • Explore the interworking and considerations to gain regulatory acceptance in the EU in 2022
Used as a way to eliminate duplicate data entry, eConsent helps with studies at the site, sponsor, and CROs level to achieve success. eConsent simplifies the consent learning process for patients, digitizes the enrollment process, and onboards patients directly the electronic data capture platform.
  • Lead your DCT with more consistent and more reliable data than paper sources could provide
  • Enhance operations and provide real-time insights for reduced site burden
  • Increase participant retention through better participant comprehension with eConsent
Navigate regulatory discussions regarding endpoints and investigator compensation model changes. Overcome internal barriers to broader adoption for remote observation in virtual clinical trials
  • Discuss in depth objective and subjective endpoints as well as continuous, categorical, and event-time endpoints
  • Outline a strategy to choose an innovation that best fits your organization and validates endpoints
  • Build a case for the broader adoption of digital endpoints including digital biomarkers
As technology improves and vendors diversify, there are far more digital clinical measures available for your use. Explore uncommon remote monitoring applications and examples of what not to do!
  • Analyze real-time monitoring to meet data cleaning timelines and deliverables for data cuts
  • Proactive data monitoring for high-enrolling sites
  • Realize efficiencies through reduced monitor travel, remote monitoring SOPs and guidelines
Create user ability efficiencies to omit the exclusion of patients who are not tech savvy or may not possess a device capable of downloading the technology apps.
  • Build streamlined, multiple portals & logins into one central site
  • Enable training personnel on systems that cover multiple technologies rather than per technology
  • Offer streamlined options, easy workflows and greater accessibility
A recent study from the Cleveland Clinic, surveyed virtual visits and the average overall satisfaction score was 4.4 out of 5, with about 82% of respondents saying their virtual visit was as good as an in-person visit with a clinician. Ensure proper operationalized remote strategies are implemented to help the overall success of your remote patient monitoring.
  • Drive out apprehension, hesitation, and doubt and demonstrate value in your next DCT
  • Reduce the site visits to decrease the burden for both patients and caregivers, contributing to patient retention
  • Enable a more patient-centric approach by allowing patients to participate in clinical trials from their home
Register Now

This window is secured by 256 bit encryption on a PCI compliant network. Click here to view this window in its own page.

Subscribe to Conference Updates
Join our e-newsletter list to follow closely all news.
Event Partners
15
Speakers
21
Days
251
Participants
125
Workshops
90
Venue
Contact Us